Galera Therapeutics, Inc. (GRTX)
OTCMKTS · Delayed Price · Currency is USD
0.0850
-0.0030 (-3.41%)
Jun 16, 2026, 1:45 PM EST
Galera Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 5.5 | 6.38 | 8.29 | 18.26 | 4.27 | 19.86 |
Short-Term Investments | - | - | - | - | 27.33 | 51.36 |
Cash & Short-Term Investments | 5.5 | 6.38 | 8.29 | 18.26 | 31.6 | 71.22 |
Cash Growth | -17.74% | -23.09% | -54.60% | -42.22% | -55.63% | -2.14% |
Other Receivables | - | - | 0.64 | - | 3.24 | - |
Receivables | - | - | 0.64 | - | 3.24 | - |
Prepaid Expenses | 0.56 | 0.72 | 1.08 | 3.37 | 3.65 | 6.18 |
Restricted Cash | - | - | - | - | 0.05 | - |
Total Current Assets | 6.06 | 7.1 | 10 | 21.63 | 38.54 | 77.39 |
Property, Plant & Equipment | - | - | - | 1.28 | 0.48 | 0.82 |
Goodwill | - | - | - | 0.88 | 0.88 | 0.88 |
Other Intangible Assets | - | - | - | 2.26 | 2.26 | 2.26 |
Other Long-Term Assets | 0.1 | 0.1 | 0.1 | 0.09 | 1.88 | 1.96 |
Total Assets | 6.16 | 7.2 | 10.1 | 26.14 | 44.04 | 83.31 |
Accounts Payable | 0.7 | 0.27 | 1.28 | 1.38 | 3.58 | 5.04 |
Accrued Expenses | 0.3 | 0.38 | 0.39 | 3.45 | 9.75 | 7.63 |
Current Portion of Leases | - | - | - | 0.13 | 0.04 | 0.26 |
Total Current Liabilities | 1.14 | 0.65 | 1.67 | 4.96 | 13.38 | 12.94 |
Long-Term Debt | - | - | 151.05 | 151.05 | 139.64 | 128.06 |
Long-Term Leases | - | - | - | 1.12 | - | 0.04 |
Long-Term Deferred Tax Liabilities | - | - | - | 0.2 | 0.2 | 0.27 |
Other Long-Term Liabilities | - | - | 1.06 | - | - | - |
Total Liabilities | 1.14 | 0.65 | 153.77 | 157.33 | 153.22 | 141.32 |
Common Stock | 0.08 | 0.08 | 0.08 | 0.05 | 0.03 | 0.03 |
Additional Paid-In Capital | 309.57 | 311.21 | 308.25 | 306.17 | 269.14 | 258.09 |
Retained Earnings | -308.92 | -307.31 | -456.36 | -437.41 | -378.32 | -316.1 |
Comprehensive Income & Other | - | - | - | - | -0.02 | -0.01 |
Total Common Equity | 0.73 | 3.97 | -148.04 | -131.19 | -109.18 | -58 |
Shareholders' Equity | 5.02 | 6.55 | -143.67 | -131.19 | -109.18 | -58 |
Total Liabilities & Equity | 6.16 | 7.2 | 10.1 | 26.14 | 44.04 | 83.31 |
Total Debt | - | - | 151.05 | 152.3 | 139.68 | 128.37 |
Net Cash (Debt) | 5.5 | 6.38 | -142.76 | -134.04 | -108.08 | -57.15 |
Net Cash Per Share | 0.06 | 0.06 | -2.61 | -3.01 | -3.99 | -2.22 |
Filing Date Shares Outstanding | 160.43 | 75.46 | 75.46 | 54.39 | 42.83 | 26.8 |
Total Common Shares Outstanding | 75.46 | 75.46 | 75.46 | 54.39 | 28.51 | 26.46 |
Working Capital | 4.92 | 6.45 | 8.34 | 16.67 | 25.16 | 64.46 |
Book Value Per Share | 0.01 | 0.05 | -1.96 | -2.41 | -3.83 | -2.19 |
Tangible Book Value | 0.73 | 3.97 | -148.04 | -134.32 | -112.32 | -61.14 |
Tangible Book Value Per Share | 0.01 | 0.05 | -1.96 | -2.47 | -3.94 | -2.31 |
Machinery | - | - | - | 0.48 | 1.87 | 1.85 |
Leasehold Improvements | - | - | - | 0.05 | 0.27 | 0.26 |